Best Weight Loss Drug When You Have a Lot to Lose

When you have 80, 100, or more pounds to lose, the question isn’t just which drug works, but which one works hardest. For most people starting at a higher BMI, tirzepatide (Zepbound, Mounjaro) produces the largest average weight loss among approved options, followed by semaglutide (Wegovy, Ozempic). People with more weight to begin with often lose more total pounds, and higher-BMI groups have shown some of the biggest percentage results in trials. Here’s how the choices compare and what to expect when your starting point is higher.

Why Starting BMI Matters

Higher starting weight changes the math in a few ways. There’s simply more fat to lose, so total pounds lost are often greater. And in trials, people with more severe obesity have sometimes achieved larger percentage reductions, not smaller ones. A meta-analysis of semaglutide trials published in Frontiers in Endocrinology in 2023 found that participants with class II obesity (a BMI of 35 or higher) tended to lose more weight than those with lower BMIs, especially at higher doses and longer durations.

That’s encouraging if you’ve been told, or assumed, that having a lot to lose makes these drugs less likely to work. The opposite is often closer to the truth.

Comparing the Most Effective Options

TrimRx offers compounded semaglutide and compounded tirzepatide as well as the brand GLP-1s, so the two most effective approved options are available after a provider review. For big weight loss goals, reaching and maintaining the highest tolerated dose tends to matter, which is why a slow, steady dose increase is part of the plan. Retatrutide, a triple-hormone drug, has produced even larger weight loss in earlier studies, but it remains investigational and is not available for prescription, so it isn’t something to count on today. You can read more about the service on the TrimRx homepage.

A realistic expectation helps. Consider a hypothetical patient starting at a BMI of 42 who wants to lose a large amount. On tirzepatide, average trial results would put a loss in the neighborhood of one-fifth of his body weight within a bit over a year, which for him could mean a substantial change. Results vary from person to person, and the pace is gradual rather than sudden.

What Else Affects Your Results

The medication is one lever, but a few things shape how far it takes you. Staying consistent and reaching an effective dose matters more than starting fast. Protein intake and resistance training help protect muscle, which is especially relevant when losing a lot of weight. And because these are long-term treatments, planning for maintenance from the start tends to produce better staying power than treating it as a short sprint.

Frequently Asked Questions

Which weight loss drug works best for a high BMI?

Among approved options, tirzepatide produces the largest average weight loss, with semaglutide next. Higher-BMI groups have shown strong results in trials, so a high starting point doesn’t mean smaller results.

Will I lose more weight because I have more to lose?

Often you’ll lose more total pounds, and sometimes a larger percentage too. Trials in more severe obesity have shown some of the biggest reductions, though individual results vary.

Is there anything stronger coming?

Retatrutide has shown even larger weight loss in earlier trials, but it’s investigational and not yet available. For now, the most effective available options are tirzepatide and semaglutide.

To find out which option suits your goals, you can take the TrimRx quiz for a licensed provider’s review.

This article is for educational purposes and is not medical advice. Retatrutide is investigational and not FDA-approved. Weight loss treatment for higher BMI should be guided by a qualified healthcare provider. Individual results vary.